8-Ethyl irinotecan
CAS: 947687-02-7
Ref. 3D-XMB68702
1mg | Discontinued | ||
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued |
Product Information
- [1,4′-Bipiperidine]-1′-carboxylic acid, (4S)-4,8,11-triethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester
- (4S)-4,8,11-Triethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl [1,4′-bipiperidine]-1′-carboxylate
8-Ethyl irinotecan is an inhibitor of peptide-activated protein kinase (PAPK) that belongs to the class of ligands. It has been shown to activate PAPK by binding to the receptor and activating it in a phosphorylation-dependent manner. 8-Ethyl irinotecan may be used as a research tool for understanding the function of PAPK in cancer, cardiovascular disease, and other diseases. This agent also binds to ion channels and may be used as an experimental drug for treating epilepsy. 8-Ethyl irinotecan is a high purity product that can be used in life science research.